51 related articles for article (PubMed ID: 2954683)
1. [Discovery and demonstration of the tumor growth inhibitor derived from human fibroblast-like cell lines].
Wu KF; Pope JH; Ellem KA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):1-6. PubMed ID: 2954683
[No Abstract] [Full Text] [Related]
2. [Partial purification and characterization of the tumor growth inhibitor derived from human fibroblast-like cell lines].
Wu KF; Sculley TB; Pope JH; Ellem KA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):7-12. PubMed ID: 2954694
[No Abstract] [Full Text] [Related]
3. [Effect of human fibroblast derived inhibitor on tumor and transformed cell proliferation and differentiation].
Song Y; Wu K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):50-5. PubMed ID: 1831701
[TBL] [Abstract][Full Text] [Related]
4. [Significance and modulation of production of tumor growth inhibitor derived from human embryonic myofibroblasts].
Wu KF
Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):419-21. PubMed ID: 2699449
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of growth of certain human tumour cell lines by a factor derived from human fibroblast-like cell lines. I. Demonstration by mixed culture and by use of cell washings.
Wu KF; Pope JH; Ellem KA
Int J Cancer; 1985 Apr; 35(4):477-82. PubMed ID: 3988370
[TBL] [Abstract][Full Text] [Related]
6. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
7. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
8. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative activity of natural interferon-alpha, isotretinoin and their combination varies in different human melanoma cell lines.
Schaber B; Mayer P; Schreiner T; Rassner G; Fierlbeck G
Melanoma Res; 1994 Oct; 4(5):319-26. PubMed ID: 7858417
[TBL] [Abstract][Full Text] [Related]
10. Heparin localization and fine structure regulate Burkitt's lymphoma growth.
Berry D; Lynn DM; Berry E; Sasisekharan R; Langer R
Biochem Biophys Res Commun; 2006 Sep; 348(3):850-6. PubMed ID: 16904641
[TBL] [Abstract][Full Text] [Related]
11. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
12. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
13. Identification of cell types in human melanoma cultures using a panel of morphological, cytochemical and immunological tests.
Delcroix M; Libert A; Lejeune FJ
Anticancer Res; 1986; 6(6):1369-75. PubMed ID: 3101577
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth inhibitor.
Rogalsky V; Svet-Moldavsky I; Arlin Z; Den T; Holland JF
Biomed Pharmacother; 1988; 42(8):547-53. PubMed ID: 3224159
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro.
Ohnuma T; Li FL; Holland JF
Anticancer Res; 1997; 17(4A):2455-8. PubMed ID: 9252662
[TBL] [Abstract][Full Text] [Related]
16. Effect of medroxyprogesterone and an aorta-derived cell growth inhibitor on B16 melanoma in mice.
Eisenstein R; Schumacher B; Hsiao K; Eisenstein N; Lemke M; Anderson T; Harper E
J Natl Cancer Inst; 1984 Apr; 72(4):885-8. PubMed ID: 6323811
[TBL] [Abstract][Full Text] [Related]
17. Differential segregation patterns of human chromosomes in somatic cell hybrids constructed with human B-lymphocytes and human melanoma cells.
Glassy MC; Ferrone S
Cancer Res; 1982 Oct; 42(10):3971-3. PubMed ID: 6980701
[TBL] [Abstract][Full Text] [Related]
18. Negative trans-acting mechanisms controlling expression of platelet-derived growth factor A and B MRNA in somatic cell hybrids.
Levéen P; Betsholtz C; Westermark B
Exp Cell Res; 1993 Aug; 207(2):283-9. PubMed ID: 8344381
[TBL] [Abstract][Full Text] [Related]
19. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Iwata KK; Fryling CM; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2689-94. PubMed ID: 3857121
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis.
Gallagher PG; Bao Y; Prorock A; Zigrino P; Nischt R; Politi V; Mauch C; Dragulev B; Fox JW
Cancer Res; 2005 May; 65(10):4134-46. PubMed ID: 15899804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
